Compare VELO & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VELO | FONR |
|---|---|---|
| Founded | 2014 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.9M | 116.9M |
| IPO Year | N/A | 1987 |
| Metric | VELO | FONR |
|---|---|---|
| Price | $18.13 | $18.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 152.6K |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.08 |
| Revenue | $49,158,000.00 | ★ $105,434,318.00 |
| Revenue This Year | $11.94 | N/A |
| Revenue Next Year | $56.44 | N/A |
| P/E Ratio | ★ N/A | $17.23 |
| Revenue Growth | ★ 59.44 | 3.36 |
| 52 Week Low | $1.43 | $12.00 |
| 52 Week High | $23.84 | $18.86 |
| Indicator | VELO | FONR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 79.52 |
| Support Level | N/A | $18.50 |
| Resistance Level | N/A | $18.67 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 66.67 |
Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.